Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,475,194
+$5,762,739 QoQ
Shares Held
279,900
-6.2% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#60
of 1,036 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $386,755,559 across 13 Drug Manufacturers - General names. BIIB ranks #2 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
528,937 | $67,968,404 | |
| 2 | BIIB |
Biogen Inc.
This page
|
279,900 | $60,475,194 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
892,969 | $51,452,873 | |
| 4 | JNJ |
Johnson & Johnson
|
200,512 | $50,924,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
381,851 | $48,243,055 | |
| 6 | ABBV |
AbbVie Inc.
|
108,867 | $27,395,291 | |
| 7 | LLY |
ELI LILLY & Co
|
21,971 | $26,352,678 | |
| 8 | PFE |
Pfizer Inc
|
916,205 | $22,062,216 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,475,194 | 279,900 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $54,712,455 | 298,437 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $48,715,615 | 276,809 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $37,891,359 | 270,498 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,532,583 | 163,489 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,578,359 | 99,228 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,705,607 | 89,626 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,227,344 | 42,444 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,460,983 | 23,557 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $953,308 | 3,684 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,998,844 | 19,450 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,872,507 | 31,148 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,525,568 | 19,874 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,086,743 | 18,369 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,967,972 | 11,116 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,293,019 | 16,147 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,315,333 | 25,239 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,419,353 | 10,084 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,888,848 | 13,742 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,007,645 | 2,910 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,147,014 | 14,824 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,633,738 | 23,008 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,806,278 | 31,043 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $26,723,429 | 99,882 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $42,387,010 | 133,975 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||